Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M502671200 on October 27, 2005

J. Biol. Chem., Vol. 280, Issue 52, 42984-42993, December 30, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/52/42984    most recent
M502671200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Du, Y.
Right arrow Articles by Gallo, K. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Du, Y.
Right arrow Articles by Gallo, K. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Cdc42 Induces Activation Loop Phosphorylation and Membrane Targeting of Mixed Lineage Kinase 3*

Yan Du{ddagger}, Barbara C. Böck{ddagger}1, Karen A. Schachter§, Mary Chao§, and Kathleen A. Gallo{ddagger}§¶2

From the Departments of {ddagger}Physiology and §Biochemistry and Molecular Biology and the Cell and Molecular Biology Program, Michigan State University, East Lansing, Michigan 48824

Mixed lineage kinase 3 (MLK3) functions as a mitogen-activated protein kinase kinase kinase to activate multiple mitogen-activated protein kinase pathways. Our current studies demonstrate that lack of MLK3 blocks signaling of activated Cdc42 to c-Jun N-terminal kinase, giving strong support for the idea that Cdc42 is a physiological activator of MLK3. We show herein that Cdc42, in a prenylation-dependent manner, targets MLK3 from a perinuclear region to membranes, including the plasma membrane. Cdc42-induced membrane targeting of MLK3 is independent of MLK3 catalytic activity but depends upon an intact Cdc42/Rac-interactive binding motif, consistent with MLK3 membrane translocation being mediated through direct binding of Cdc42. Phosphorylation of the activation loop of MLK3 requires MLK3 catalytic activity and is induced by Cdc42 in a prenylation-independent manner, arguing that Cdc42 binding is sufficient for activation loop autophosphorylation of MLK3. However, membrane targeting is necessary for full activation of MLK3 and maximal signaling to JNK. We previously reported that MLK3 is autoinhibited through an interaction between its N-terminal SH3 domain and a proline-containing sequence found between the leucine zipper and the CRIB motif of MLK3. Thus we propose a model in which GTP-bound Cdc42/Rac binds MLK3 and disrupts SH3-mediated autoinhibition leading to dimerization and activation loop autophosphorylation. Targeting of this partially active MLK3 to membranes likely results in additional phosphorylation events that fully activate MLK3 and its ability to maximally signal through the JNK pathway.


Received for publication, March 10, 2005 , and in revised form, October 6, 2005.

* This work was supported by American Cancer Society Research Scholar Grant RSG-03-084 (to K. A. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Present address: German Cancer Research Center, Molecular Neuro-Oncology, Heidelberg, Germany.

2 To whom correspondence should be addressed: Dept. of Physiology, 4180 Biomedical and Physical Sciences Bldg., Michigan State University, East Lansing, MI 48824. Tel.: 517-355-6475 (ext. 1159); Fax: 517-355-5125; E-mail: gallok{at}msu.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
JDRHome page
J.F. Schindler, J.B. Monahan, and W.G. Smith
p38 Pathway Kinases as Anti-inflammatory Drug Targets
Journal of Dental Research, September 1, 2007; 86(9): 800 - 811.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. A. Schachter, Y. Du, A. Lin, and K. A. Gallo
Dynamic Positive Feedback Phosphorylation of Mixed Lineage Kinase 3 by JNK Reversibly Regulates Its Distribution to Triton-soluble Domains
J. Biol. Chem., July 14, 2006; 281(28): 19134 - 19144.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Z. Sui, S. Fan, L. Sniderhan, E. Reisinger, A. Litzburg, G. Schifitto, H. A. Gelbard, S. Dewhurst, and S. B. Maggirwar
Inhibition of Mixed Lineage Kinase 3 Prevents HIV-1 Tat-Mediated Neurotoxicity and Monocyte Activation
J. Immunol., July 1, 2006; 177(1): 702 - 711.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement